Zhurnal mikrobiologii, epidemiologii, i immunobiologii 2013-01-01

[Induction and protective properties of antibodies against muramyl peptides of gram-negative bacteria].

M V Pashchenkov, V G Pak, B I Alkhazova, V L L'vov, B V Pinegin

Index: Zh. Mikrobiol. Epidemiol. Immunobiol. (2) , 64-73, (2013)

Full Text: HTML

Abstract

Characterize the role of humoral immune response in mechanisms of action of muramyl dipeptide immune stimulators.Mice were immunized by a complex of muramyl peptides (CMP) obtained from Salmonella typhi peptidoglycan and consisting of 3 components: 1) N-acetyl-D-glucoasminyl-(beta1- > 4)-N-acetyl-D-muramoyl-L-alanyl-D-isoglutaminyl-meso-diaminopimelic acid (GMtri); 2) N-acetyl-D-glucosaminyl-(beta1- > 4)-N-acetyl-D-muramoyl-L-alanyl-D-isoglutaminyl-meso-diaminopimeloyl-D-alanine (GMtetra) and 3) GMtetra dimer (diGMtetra), in which monomeric residues of GMtetra are linked by an amid bond between carboxyl group of terminal D-alanine of one of GMtetra residues and omega-amino group of meso-diaminopimelic acid of the other GMtetra residue.Immunization resulted in a multifold increase of IgM, IgG1 and IgG2a titers against CMP. Antibodies were directed against the whole molecule of diGMtetra and did not recognize its fragments. Sera of mice immunized with CMP protected the mice from lethal infection with Gram-negative (S. typhimurium) but not Gram-positive (Staphylococcus aureus) microorganisms.Induction of protective antibodies may present a novel mechanism of action of muramyl dipeptide immune stimulators.


Related Compounds

  • Ac-muramyl-Ala-D-...

Related Articles:

Enhanced anti-tumor immune responses and delay of tumor development in human epidermal growth factor receptor 2 mice immunized with an immunostimulatory peptide in poly(D,L-lactic-co-glycolic) acid nanoparticles.

2015-01-01

[Breast Cancer Res. 17 , 48, (2015)]

The crosstalk between TLR2 and NOD2 in Aspergillus fumigatus keratitis.

2015-04-01

[Mol. Immunol. 64(2) , 235-43, (2015)]

Sensing of commensal organisms by the intracellular sensor NOD1 mediates experimental pancreatitis.

2012-08-24

[Immunity 37(2) , 326-38, (2012)]

Mifamurtide in metastatic and recurrent osteosarcoma: a patient access study with pharmacokinetic, pharmacodynamic, and safety assessments.

2014-02-01

[Pediatr. Blood Cancer 61(2) , 238-44, (2014)]

Mifamurtide for high-grade, resectable, nonmetastatic osteosarcoma following surgical resection: a cost-effectiveness analysis.

2013-12-01

[Value Health 16(8) , 1123-32, (2013)]

More Articles...